News FDA sets July verdict date for Leqembi, after adcomm meeting After priority review, regulator will consider upgrading the drug's status to full approval.
News FDA said no to trials of Elon Musk’s Neuralink chip; report Regulator has numerous concerns about the implantable device's safety, according to Reuters.
R&D JP Morgan 2023 - Astrocyte Pharmaceuticals pharmaphorum spoke with Astrocyte's Kevin Sheth, William Korinek, and James D. Lechleiter
R&D JP Morgan 2023 - Stefan Weber and Ravi Anand pharmaphorum sits down with Stefan Weber and Ravi Anand of neurology-focused biotech Newron.
News Novartis drops Huntington's drug on phase 2b data Tucked away inside Novartis' fourth-quarter results update this morning is the news that the company has pulled the plug on a drug candidate for Huntington's disease after
News Roche, Boehringer tap biosensor firms for patient studies Roche and Boehringer Ingelheim have both formed partnerships with tech companies this week to develop and deploy wearable biosensor te
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
